Annotation Detail
Information
- Associated Genes
- COMT
- Associated Variants
-
DRD2 c.724-353G>T
(
ENST00000544518.5,
ENST00000346454.7,
ENST00000538967.5,
ENST00000542968.5,
ENST00000362072.8 )
COMT p.Val158Met (p.V158M) ( ENST00000361682.11, ENST00000403184.5, ENST00000403710.5, ENST00000406520.7, ENST00000407537.5, ENST00000428707.2, ENST00000449653.5, ENST00000676678.1, ENST00000678255.1, ENST00000678769.1, ENST00000678868.1 )
DRD2 c.724-353G>T ( ENST00000346454.7, ENST00000362072.8, ENST00000538967.5, ENST00000542968.5, ENST00000544518.5 )
COMT p.Val158Met (p.V158M) ( ENST00000361682.11, ENST00000403184.5, ENST00000403710.5, ENST00000406520.7, ENST00000407537.5, ENST00000428707.2, ENST00000449653.5, ENST00000676678.1, ENST00000678255.1, ENST00000678769.1, ENST00000678868.1 ) - Associated Disease
- schizophrenia
- Source Database
- DisGeNET
- Description
- We assessed catechol-O-methyltransferase (COMT) Val108/158Met (rs4680) and dopamine D2 receptor (DRD2) G-T (rs2283265) single nucleotide polymorphisms and functional magnetic resonance imaging during an emotional response inhibition test in 43 healthy adults and 27 people with schizophrenia to determine the extent to which COMT Val108/158Met and DRD2 G-T polymorphisms combine to influence prefrontal response to cognitive-affective challenges.
- Pubmed
- 24495967
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.345417491171353
- Year of publication
- 2013
Drugs